| Drosophila oogenesis as a bio-marker responding to EMF sources LH Margaritis, AK Manta, KD Kokkaliaris, D Schiza, K Alimisis, G Barkas, ... Electromagnetic Biology and Medicine 33 (3), 165-189, 2014 | 56 | 2014 |
| Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis M Michailidou, V Giannouli, V Kotsikoris, O Papadodima, G Kontogianni, ... European Journal of Medicinal Chemistry 121, 143-157, 2016 | 29 | 2016 |
| BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis K Koumaki, G Kontogianni, V Kosmidou, F Pahitsa, E Kritsi, M Zervou, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (4), 166061, 2021 | 18 | 2021 |
| Hepatic gene expression variations in response to high-fat diet-induced impaired glucose tolerance using RNAseq analysis in collaborative cross mouse population HJ Abu-Toamih Atamni, G Kontogianni, I Binenbaum, R Mott, ... Mammalian Genome 30, 260-275, 2019 | 13 | 2019 |
| Dissecting the mutational landscape of cutaneous melanoma: an Omic analysis based on patients from Greece G Kontogianni, G Piroti, I Maglogiannis, A Chatziioannou, O Papadodima Cancers 10 (4), 96, 2018 | 13 | 2018 |
| Container-aided integrative QTL and RNA-seq analysis of Collaborative Cross mice supports distinct sex-oriented molecular modes of response in obesity I Binenbaum, HAT Atamni, G Fotakis, G Kontogianni, T Koutsandreas, ... BMC genomics 21, 1-13, 2020 | 11 | 2020 |
| Genomics of cutaneous melanoma: focus on next-generation sequencing approaches and bioinformatics O Papadodima, G Kontogianni, G Piroti, I Maglogiannis, A Chatziioannou J. Transl. Genet. Genom 3 (7), 2019 | 5 | 2019 |
| Redesigning EHRs and clinical decision support systems for the precision medicine era I Maglogiannis, T Goudas, A Billiris, H Karanikas, I Valavanis, ... Proceedings of the 16th International Conference on Engineering Applications …, 2015 | 5 | 2015 |
| An integrated platform for skin cancer heterogenous and multilayered data management I Maglogiannis, G Kontogianni, O Papadodima, H Karanikas, A Billiris, ... Journal of Medical Systems 45 (1), 10, 2021 | 4 | 2021 |
| Exploring the Molecular Determinants of Tumor-Stroma Interaction in Non-Small Cell Lung Cancer Through the Utilization of RNA-Seq Data from Lung Biopsies G Kontogianni, O Papadodima, A Mitrakas, I Maglogiannis, ... XIV Mediterranean Conference on Medical and Biological Engineering and …, 2016 | 3 | 2016 |
| Integrative Bioinformatic Analysis of a Greek Epidemiological Cohort Provides Insight into the Pathogenesis of Primary Cutaneous Melanoma G Kontogianni, O Papadodima, I Maglogiannis, K Frangia-Tsivou, ... Artificial Intelligence Applications and Innovations: 12th IFIP WG 12.5 …, 2016 | 3 | 2016 |
| A review on state-of-the-art computer-based approaches for the early recognition of malignant melanoma G Kontogianni, I Maglogiannis Advanced Computational Intelligence in Healthcare-7: Biomedical Informatics …, 2020 | 2 | 2020 |
| An RNA-seq analysis from non-small cell lung cancer biopsies suggests an important role for aberrant alternative splicing in its pathophysiology G Kontogianni, O Papadodima, A Mitrakas, I Maglogiannis, ... Health and Technology 7, 133-140, 2017 | 2 | 2017 |
| Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer ACRP Charles Ricordel, L. Chaillot, E. I. Vlachavas, M. Logotheti, A ... Scientific Reports 13 (3626 (2023)), 11, 2023 | 1* | 2023 |
| A Comprehensive Analysis of Cutaneous Melanoma Patients in Greece Based on Multi-Omic Data G Kontogianni, K Voutetakis, G Piroti, K Kypreou, I Stefanaki, ... Cancers 15 (3), 815, 2023 | | 2023 |
| Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma https://www.biorxiv.org/content/10.1101/2022.04.30.487775v1.article-info, 2022 | | 2022 |
| Development of a methodology of computational intelligence for robust composite biomarker discovery: Targeting breakthrough in the therapeutic management of melanoma GA Kontogianni PQDT-Global, 2019 | | 2019 |
